Related Experiment Video

Updated: Jun 14, 2026

A Multiplexed Luciferase-based Screening Platform for Interrogating Cancer-associated Signal Transduction in Cultured Cells
10:13

A Multiplexed Luciferase-based Screening Platform for Interrogating Cancer-associated Signal Transduction in Cultured Cells

Published on: July 3, 2013

RUNX3 is multifunctional in carcinogenesis of multiple solid tumors

L S H Chuang1, Y Ito

  • 1Cancer Biology Program, Cancer Science Institute of Singapore, National University of Singapore, Singapore.

Oncogene
|March 30, 2010
PubMed

Insights

RUNX3 inactivation is a key factor in many cancers, acting as a tumor suppressor. Understanding its dual role in tumorigenesis is crucial for cancer detection and prognosis.

Area of Science:

  • Oncology and molecular biology, focusing on cancer research.

Background:

  • RUNX3 plays a critical role in tumor pathogenesis.
  • Functional inactivation of RUNX3 (mutation, silencing, mislocalization) is common in solid tumors.
  • RUNX3 inactivation is an early event and a risk factor in tumorigenesis.

Purpose of the Study:

  • To review the tumor-suppressive functions of RUNX3.
  • To explore the pleiotropic properties of RUNX3 in regulating signaling pathways.
  • To summarize recent findings linking RUNX3 to tumor suppression.

Main Methods:

  • This is a review article, summarizing existing research findings.
  • Literature review of studies investigating RUNX3's role in cancer.
  • Analysis of data on RUNX3's impact on tumor pathogenesis.

Main Results:

  • RUNX3 inactivation is frequently observed in diverse solid tumors.
  • RUNX3 acts as a tumor suppressor, regulating major signaling pathways.
  • RUNX3 can also exhibit oncogenic functions in certain tumor types, though the mechanism is unclear.

Conclusions:

  • RUNX3 inactivation is a significant risk factor in tumorigenesis.
  • The dual role of RUNX3 (suppressive vs. oncogenic) has clinical implications for cancer detection and prognosis.
  • Further research is needed to elucidate the switch between RUNX3's tumor-suppressive and oncogenic activities.

More Related Videos

Multidimensional Coculture System to Model Lung Squamous Carcinoma Progression07:53

Multidimensional Coculture System to Model Lung Squamous Carcinoma Progression

Published on: March 17, 2020

Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma13:18

Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma

Published on: March 3, 2023

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA (lncRNA)...